Literature DB >> 15637090

Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Cunping Qiu1, Liang Shan, Minshu Yu, Elizabeth G Snyderwine.   

Abstract

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a mammary gland carcinogen present in the human diet. Herein, the expression of estrogen receptor alpha (ERalpha), estrogen receptor beta (ER beta) and progesterone receptor (PR) was examined in mammary gland carcinomas induced by PhIP in female Sprague-Dawley rats. Quantitative real-time polymerase chain reaction demonstrated that ER alpha, ER beta and PR were statistically elevated by 3-, 4- and 8-fold in carcinomas compared with normal mammary glands. By immunohistochemistry, carcinomas showed statistically higher nuclear expression of all three steroid receptors with the majority of carcinomas showing at least 10% of epithelial cells stained for ER alpha (49/55, 89%), ER beta (41/55, 75%) and PR (48/55, 87%). Furthermore, the level of expression of the three steroid hormone receptors was positively correlated with each other across the bank of carcinomas (Spearman analysis, P < 0.05). The expression of ER alpha in carcinomas was associated with tumor grade, extent of nuclear pleomorphism and cellular proliferation as measured by proliferating cell nuclear antigen (PCNA) and phospho-Rb immunostaining (Spearman analysis, P < 0.05). Confocal microscopy was used to measure the percentage of epithelial cells showing nuclear colocalization of receptors, PCNA, and cyclin D1. Colocalization of the receptors, and the colocalization of the receptors with PCNA and cyclin D1 was strikingly higher in carcinomas than in the normal mammary gland. In carcinoma cells, 37% of ER alpha positive epithelial cells were colocalized with PCNA in contrast to just 0.25% of cells in the normal mammary gland. The findings from this study indicate that ER alpha, ER beta and PR were co-upregulated and nuclear localized in epithelial cells from rat mammary carcinomas compared with normal mammary glands, and that the co-upregulation was positively correlated with proliferation and cell cycle progression in carcinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637090     DOI: 10.1093/carcin/bgi013

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Meat, dairy, and cancer.

Authors:  Zaynah Abid; Amanda J Cross; Rashmi Sinha
Journal:  Am J Clin Nutr       Date:  2014-05-21       Impact factor: 7.045

2.  Mammary carcinogen-protein binding potentials: novel and biologically relevant structure-activity relationship model descriptors.

Authors:  A R Cunningham; S Qamar; C A Carrasquer; P A Holt; J M Maguire; S L Cunningham; J O Trent
Journal:  SAR QSAR Environ Res       Date:  2010-07       Impact factor: 3.000

3.  High corn oil and extra virgin olive oil diets and experimental mammary carcinogenesis: clinicopathological and immunohistochemical p21Ha-Ras expression study.

Authors:  Irmgard Costa; Raquel Moral; Montserrat Solanas; Francisco Javier Andreu; Maria Carmen Ruiz de Villa; Eduard Escrich
Journal:  Virchows Arch       Date:  2011-01-15       Impact factor: 4.064

4.  Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer.

Authors:  Hae-Jeung Lee; Kana Wu; David G Cox; David Hunter; Susan E Hankinson; Walter C Willett; Rashmi Sinha; Eunyoung Cho
Journal:  Nutr Cancer       Date:  2013-10-07       Impact factor: 2.900

5.  Racial disparities in red meat and poultry intake and breast cancer risk.

Authors:  Urmila Chandran; Gary Zirpoli; Gregory Ciupak; Susan E McCann; Zhihong Gong; Karen Pawlish; Yong Lin; Kitaw Demissie; Christine B Ambrosone; Elisa V Bandera
Journal:  Cancer Causes Control       Date:  2013-10-05       Impact factor: 2.506

6.  Red meat consumption during adolescence among premenopausal women and risk of breast cancer.

Authors:  Eleni Linos; Walter C Willett; Eunyoung Cho; Graham Colditz; Lindsay A Frazier
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07-31       Impact factor: 4.254

7.  Expression of estrogen receptor alpha and beta in breast cancers of pre- and post-menopausal women.

Authors:  Blanca Murillo-Ortiz; Elva Pérez-Luque; J M Malacara; Leonel Daza-Benítez; Martha Hernández-González; Luis Benítez-Bribiesca
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

8.  Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response.

Authors:  Blanca Murillo-Ortiz; Horacio Astudillo-De la Vega; Sebastian Castillo-Medina; J M Malacara; Luis Benitez-Bribiesca
Journal:  BMC Cancer       Date:  2006-08-15       Impact factor: 4.430

9.  Spontaneous Mammary Adenocarcinoma in a Twelve-week-old Female Sprague-Dawley Rat.

Authors:  Kazuya Kuzutani; Toshiyuki Shibanushi; Yumi Kangawa; Tohru Kihara
Journal:  J Toxicol Pathol       Date:  2012-10-01       Impact factor: 1.628

10.  2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer.

Authors:  Lora J Rogers; Alexei G Basnakian; Mohammed S Orloff; Baitang Ning; Aiwei Yao-Borengasser; Vinay Raj; Susan Kadlubar
Journal:  Nutr Metab (Lond)       Date:  2016-08-20       Impact factor: 4.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.